Grantham, Mayo, Van Otterloo & Co (GMO)’s Stride LRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$789K Buy
8,946
+764
+9% +$62K ﹤0.01% 527
2025
Q4
$531K Buy
+8,182
New +$743K ﹤0.01% 574
2025
Q2
Sell
-13,420
Closed -$1.7M 653
2025
Q1
$1.7M Sell
13,420
-6,858
-34% -$867K 0.01% 387
2024
Q4
$2.11M Buy
20,278
+310
+2% +$29.5K 0.01% 371
2024
Q3
$1.7M Buy
19,968
+5,635
+39% +$436K 0.01% 386
2024
Q2
$1.01M Sell
14,333
-2,495
-15% -$166K ﹤0.01% 400
2024
Q1
$1.06M Buy
16,828
+3,890
+30% +$235K ﹤0.01% 389
2023
Q4
$768K Buy
+12,938
New +$708K ﹤0.01% 389
2020
Q1
Sell
-272,534
Closed -$5.55M 787
2019
Q4
$5.55M Sell
272,534
-197,800
-42% -$4.22M 0.04% 278
2019
Q3
$12.4M Buy
470,334
+69,323
+17% +$1.99M 0.09% 161
2019
Q2
$12.2M Sell
401,011
-19,700
-5% -$634K 0.09% 163
2019
Q1
$14.4M Buy
420,711
+354,211
+533% +$10.8M 0.1% 145
2018
Q4
$1.65M Sell
66,500
-8,900
-12% -$190K 0.01% 306
2018
Q3
$1.33M Buy
75,400
+29,600
+65% +$505K 0.01% 354
2018
Q2
$750K Buy
45,800
+4,900
+12% +$76K 0.01% 409
2018
Q1
$580K Hold
40,900
﹤0.01% 463
2017
Q4
$650K Buy
+40,900
New +$681K ﹤0.01% 428

Other funds holding LRN

Grantham, Mayo, Van Otterloo & Co (GMO)'s LRN Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Stride (LRN) stake by 9.3% in Q1 2026, buying an estimated $62K and bringing the position to 8,946 shares worth $789K. The position accounts for ﹤0.01% of the portfolio, ranked #527.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in LRN in Q4 2017 and has held it in 17 quarters since. The position peaked at $14.4M in Q1 2019. 419 funds tracked by Wall St. Rank hold LRN as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 8,946 shares of Stride worth $789K as of Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 764 Stride shares in Q1 2026, an estimated $62K.
  • Stride made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #527 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Stride in Q4 2017 and has held it in 17 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Stride position peaked at $14.4M in Q1 2019.
  • 419 funds tracked by Wall St. Rank held Stride as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.